ACADIA Pharmaceuticals Inc. (ACAD) vs Tarsus Pharmaceuticals, Inc. (TARS)
ACADIA Pharmaceuticals Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. ACADIA Pharmaceuticals Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.8B and $3.6B). Tarsus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; ACADIA Pharmaceuticals Inc. trades at 9.2×. Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against 11.8%. ACADIA Pharmaceuticals Inc. has the higher net margin (33.4% vs −7.67%) and the higher return on invested capital (15.4% vs 0.00%). Across the 17 metrics below, ACADIA Pharmaceuticals Inc. leads on 14 and Tarsus Pharmaceuticals, Inc. on 3.
Valuation
Profitability
| Metric | ACAD | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.13% | 93.28% | 65.16% |
| Operating margin | 7.59% | (8.00%) | 0.00% |
| Net margin | 33.42% | (7.67%) | 0.00% |
| Free cash flow margin | 12.79% | 9.24% | 0.00% |
| Return on equity | 35.74% | (13.68%) | (57.72%) |
| Return on assets | 25.64% | (8.40%) | (49.22%) |
| Return on invested capital | 15.42% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack